1 2386 174 YOGA AIDS BLOOD PRESSURE RECOVERY AFTER EXPOSURE OF FOREHEAD TO COLD: A PILOT STUDY. CONTEXT: HYPOTENSION THAT OCCURS AFTER A SINGLE BOUT OF AEROBIC EXERCISE ALSO ATTENUATES THE VASCULAR RESPONSE TO DISCRETE STRESSORS, AN EFFECT THAT CAN LAST FOR HOURS. IT IS UNKNOWN WHETHER THE HYPOTENSIVE BENEFITS OF TRADITIONAL EXERCISE EXTEND TO ALTERNATIVE FORMS OF MINDFUL EXERCISE, SUCH AS YOGA, TO CONFER TRANSIENT PROTECTION AGAINST NEUROVASCULAR CHALLENGES THAT INCREASE BLOOD PRESSURE (BP). OBJECTIVES: THE STUDY INTENDED TO EXAMINE THE EFFECTS OF ACUTE EXERCISE ON NEUROVASCULAR RESPONSES TO EXPOSURE OF THE FOREHEAD OF FEMALE YOGA PRACTITIONERS TO VASOCONSTRICTIVE COLD (IE, TO COLD PRESSOR STRESS). DESIGN: THE RESEARCH TEAM DESIGNED A STUDY WITH 3 CONDITIONS (IE, WITH PARTICIPANTS' PARTICIPATION IN 3 ACTIVITIES ON SEPARATE DAYS IN A REPEATED-MEASURES DESIGN). PARTICIPANTS WERE RANDOMLY ASSIGNED TO PERFORM THE ACTIVITIES IN 1 OF 3 ORDERS ACROSS SUCCESSIVE VISITS. PARTICIPANTS: PARTICIPANTS WERE 9 FEMALES, 20 TO 33 Y OLD, WHO HAD REGULARLY PRACTICED HATHA YOGA FROM 6 MO TO 12 Y BEFORE THE START OF THE STUDY. ALL PARTICIPANTS WERE NORMOTENSIVE AT ENTRY TO THE STUDY AND HAD NORMAL BODY WEIGHTS FOR THEIR HEIGHTS. INTERVENTIONS: ALL PARTICIPANTS PERFORMED 3 ACTIVITIES: (1) SELF-DIRECTED YOGA PRACTICE, THE INTERVENTION; (2) CYCLING EXERCISE AT A SELF-SELECTED INTENSITY, A POSITIVE CONTROL; AND (3) QUIET REST, A NEGATIVE CONTROL. OUTCOME MEASURES: POSTINTERVENTION, PARTICIPANTS' FOREHEADS WERE EXPOSED TO COLD. THEIR SYSTOLIC BLOOD PRESSURES (SBPS), DIASTOLIC BLOOD PRESSURES (DBPS), PULSE RATES, AND FOREARM OXYGENATION WERE ASSESSED USING NEAR-INFRARED SPECTROSCOPY. RESULTS: PARTICIPANTS' SBPS AND DBPS INCREASED DURING COLD PRESSOR STRESS UNDER ALL CONDITIONS, CONCURRENT WITH DECREASED FOREARM OXYGENATION. DURING RECOVERY FROM THE COLD, PARTICIPANTS' BPS DECLINED TO NEAR PRECOLD PRESSOR BASELINE LEVELS AFTER YOGA AND CYCLING BUT REMAINED ELEVATED AFTER QUIET REST. CONCLUSIONS: THE ENHANCED RECOVERY OF BP FROM COLD APPLIED TO THE FOREHEAD AFTER YOGA PRACTICE OR CYCLING EXERCISE SUGGESTS THAT BOTH TYPES OF EXERCISE PROMOTE A HYPOTENSIVE RESPONSE, WHICH COULD INDICATE LOWERED CARDIOVASCULAR RISK. 2018 2 1809 35 PREVENTIVE EFFECTS OF A THREE-MONTH YOGA INTERVENTION ON ENDOTHELIAL FUNCTION IN PATIENTS WITH MIGRAINE. BACKGROUND: MIGRAINE IS A NEUROVASCULAR DISORDER AND ANY INTERVENTIONS IMPROVING ENDOTHELIAL FUNCTION MAY CONTRIBUTE TO ITS TREATMENT AND PREVENTION OF VASCULAR COMPLICATIONS LIKE ISCHEMIC STROKE. YOGA HAS BEEN SHOWN TO HAVE SEVERAL BENEFICIAL EFFECTS ON CARDIOVASCULAR SYSTEMS. HOWEVER, NO RANDOMIZED CONTROLLED STUDIES TO DATE HAVE INVESTIGATED ITS EFFECTS ON ENDOTHELIAL FUNCTION OF MIGRAINEURS. METHODS: A TOTAL OF 42 WOMEN PATIENTS WITH MIGRAINE WERE ENROLLED AND RANDOMIZED INTO EITHER A YOGA EXERCISE GROUP OR A CONTROL GROUP. THE CONTROL GROUP RECEIVED ONLY MEDICATION FOR 12 WEEKS AND THE YOGA GROUP WAS PLACED IN YOGA TRAINING PROGRAM IN ADDITION TO THE SAME MEDICAL TREATMENT. BLOOD TEST WAS GIVEN FROM ALL PATIENTS IN ORDER TO MEASURE PLASMA LEVELS INTERCELLULAR ADHESION MOLECULE (ICAM) AND VASCULAR CELL ADHESION MOLECULE (VCAM) AFTER YOGA TRAINING PROGRAM. RESULTS: TOTALLY 32 PATIENTS WERE PARTICIPATED IN THE FINAL ANALYSES (YOGA: N = 18, CONTROL: N = 14). BY ANALYZING DATA BETWEEN YOGA AND CONTROL GROUPS AFTER THE TREATMENT PERIOD, THERE WAS A SIGNIFICANT DECREASED IN PLASMA LEVEL OF VCAM IN YOGA GROUP COMPARE WITH THE CONTROL GROUP (15.29 +/- 2.1 NG/ML VS. 21.70 +/- 3.0 NG/ML, P < 0.05), WHEREAS THERE WAS NO SIGNIFICANT DIFFERENCE IN ICAM LEVEL BETWEEN GROUPS (19.1 +/- 1.8 NG/ML VS. 20.97 +/- 1.9 NG/ML P > 0.05). CONCLUSIONS: IT SEEMS THAT YOGA EXERCISES, AS A COMPLEMENTARY TREATMENT BESIDE PHARMACOLOGICAL TREATMENTS, CAN BE POTENTIALLY AN EFFECTIVE WAY OF IMPROVING VASCULAR FUNCTIONS IN MIGRAINEURS. 2014 3 1898 37 RESTORATIVE YOGA AND METABOLIC RISK FACTORS: THE PRACTICING RESTORATIVE YOGA VS. STRETCHING FOR THE METABOLIC SYNDROME (PRYSMS) RANDOMIZED TRIAL. AIMS: INTENSIVE LIFESTYLE CHANGE PREVENTS TYPE 2 DIABETES BUT IS DIFFICULT TO SUSTAIN. PRELIMINARY EVIDENCE SUGGESTS THAT YOGA MAY IMPROVE METABOLIC FACTORS. WE TESTED A RESTORATIVE YOGA INTERVENTION VS. ACTIVE STRETCHING FOR METABOLIC OUTCOMES. METHODS: IN 2009-2012, WE CONDUCTED A 48-WEEK RANDOMIZED TRIAL COMPARING RESTORATIVE YOGA VS. STRETCHING AMONG UNDERACTIVE ADULTS WITH THE METABOLIC SYNDROME AT THE UNIVERSITIES OF CALIFORNIA, SAN FRANCISCO AND SAN DIEGO. WE PROVIDED LIFESTYLE COUNSELING AND A TAPERING SERIES OF 90-MIN GROUP CLASSES IN THE 24-WEEK INTERVENTION PERIOD AND 24-WEEK MAINTENANCE PERIOD. FASTING AND 2-H GLUCOSE, HBA1C, TRIGLYCERIDES, HDL-CHOLESTEROL, INSULIN, SYSTOLIC BLOOD PRESSURE, VISCERAL FAT, AND QUALITY OF LIFE WERE ASSESSED AT BASELINE, 6- AND 12-MONTHS. RESULTS: 180 PARTICIPANTS WERE RANDOMIZED AND 135 (75%) COMPLETED THE TRIAL. AT 12 MONTHS, FASTING GLUCOSE DECREASED MORE IN THE YOGA GROUP THAN IN THE STRETCHING GROUP (-0.35 MMOL/L VS. -0.03 MMOL/L; P=0.002); THERE WERE NO OTHER SIGNIFICANT DIFFERENCES BETWEEN GROUPS. AT 6 MONTHS FAVORABLE CHANGES WITHIN THE YOGA GROUP INCLUDED REDUCTIONS IN FASTING GLUCOSE, INSULIN, AND HBA1C AND AN INCREASE IN HDL-CHOLESTEROL THAT WERE NOT SUSTAINED AT 1 YEAR EXCEPT CHANGES IN FASTING GLUCOSE. THE STRETCHING GROUP HAD A SIGNIFICANT REDUCTION IN TRIGLYCERIDES AT 6 MONTHS WHICH WAS NOT SUSTAINED AT 1 YEAR BUT HAD IMPROVED QUALITY OF LIFE AT BOTH TIME-POINTS. CONCLUSIONS: RESTORATIVE YOGA WAS MARGINALLY BETTER THAN STRETCHING FOR IMPROVING FASTING GLUCOSE BUT NOT OTHER METABOLIC FACTORS. 2014 4 2213 28 THE HYPOTENSIVE EFFECT OF YOGA'S BREATHING EXERCISES: A SYSTEMATIC REVIEW. THE AIM OF THIS REVIEW WAS TO EVALUATE THE EFFECT OF PRANAYAMA (YOGA'S BREATHING EXERCISES) ON BP AND ITS APPLICABILITY IN THE TREATMENT OF HYPERTENSION. THIRTEEN TRIALS, ASSESSING ACUTE (EIGHT STUDIES) AND CHRONIC (FIVE STUDIES) BP RESPONSE TO PRANAYAMA WERE INCLUDED. SIGNIFICANT BP REDUCTIONS AFTER PRANAYAMA WERE FOUND IN BOTH ACUTE (2-10 MMHG MEAN SBP REDUCTION, N = 5 STUDIES; 1 MMHG MEAN DBP REDUCTION, N = 1 STUDY) AND CHRONIC STUDIES (4-21 MMHG MEAN SBP REDUCTION, N = 3 STUDIES; 4-7 MMHG MEAN DBP REDUCTION, N = 2 STUDIES). THE PRANAYAMA'S EFFECT ON BP WERE NOT ROBUST AGAINST SELECTION BIAS DUE TO THE LOW QUALITY OF STUDIES. BUT, THE LOWERING BP EFFECT OF PRANAYAMA IS ENCOURAGING. THE PRANAYAMA WITH SLOWER RHYTHMS AND MANIPULATION OF THE NOSTRILS, MAINLY WITH BREATHS BY THE LEFT, PRESENT BETTER RESULTS WHEN COMPARED WITH THE OTHER TYPES AND SHOULD BE THE MAIN PRANAYAMA APPLIED WHEN THE GOAL IS TO REDUCE BLOOD PRESSURE ESPECIALLY IN HYPERTENSIVE PATIENTS. 2017 5 1374 39 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 6 2715 40 YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTS WITH CARDIOVASCULAR DISEASE RISK FACTORS. OBJECTIVE: PEOPLE LIVING WITH HIV INFECTION ARE AT INCREASED RISK FOR DEVELOPING CARDIOVASCULAR DISEASE (CVD). SAFE AND EFFECTIVE INTERVENTIONS FOR LOWERING CVD RISK IN HIV INFECTION ARE HIGH PRIORITIES. WE CONDUCTED A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY TO EVALUATE WHETHER A YOGA LIFESTYLE INTERVENTION IMPROVES CVD RISK FACTORS, VIROLOGICAL OR IMMUNOLOGICAL STATUS, OR QUALITY OF LIFE (QOL) IN HIV-INFECTED ADULTS RELATIVE TO STANDARD OF CARE TREATMENT IN A MATCHED CONTROL GROUP. METHODS: SIXTY HIV-INFECTED ADULTS WITH MILD-MODERATE CVD RISK WERE ASSIGNED TO 20 WEEKS OF SUPERVISED YOGA PRACTICE OR STANDARD OF CARE TREATMENT. BASELINE AND WEEK 20 MEASURES WERE: 2-H ORAL GLUCOSE TOLERANCE TEST WITH INSULIN MONITORING, BODY COMPOSITION, FASTING SERUM LIPID/LIPOPROTEIN PROFILE, RESTING BLOOD PRESSURES, CD4 T-CELL COUNT AND PLASMA HIV RNA, AND THE MEDICAL OUTCOMES STUDY SHORT FORM (SF)-36 HEALTH-RELATED QOL INVENTORY. RESULTS: RESTING SYSTOLIC AND DIASTOLIC BLOOD PRESSURES IMPROVED MORE (P=0.04) IN THE YOGA GROUP (-5 +/- 2 AND -3 +/- 1 MMHG, RESPECTIVELY) THAN IN THE STANDARD OF CARE GROUP (+1 +/- 2 AND+2 +/- 2 MMHG, RESPECTIVELY). HOWEVER, THERE WAS NO GREATER REDUCTION IN BODY WEIGHT, FAT MASS OR PROATHEROGENIC LIPIDS, OR IMPROVEMENTS IN GLUCOSE TOLERANCE OR OVERALL QOL AFTER YOGA. IMMUNE AND VIROLOGICAL STATUS WAS NOT ADVERSELY AFFECTED. CONCLUSION: AMONG TRADITIONAL LIFESTYLE MODIFICATIONS, YOGA IS A LOW-COST, SIMPLE TO ADMINISTER, NONPHARMACOLOGICAL, POPULAR BEHAVIOURAL INTERVENTION THAT CAN LOWER BLOOD PRESSURE IN PRE-HYPERTENSIVE HIV-INFECTED ADULTS WITH MILD-MODERATE CVD RISK FACTORS. 2010 7 938 39 EFFECTS OF 1-YEAR YOGA ON CARDIOVASCULAR RISK FACTORS IN MIDDLE-AGED AND OLDER ADULTS WITH METABOLIC SYNDROME: A RANDOMIZED TRIAL. BACKGROUND: METABOLIC SYNDROME (METS) IS A CLUSTERING OF CARDIOVASCULAR RISK FACTORS, WHICH IS ASSOCIATED WITH DIABETES MELLITUS AND CARDIOVASCULAR DISEASE. LIFESTYLE INTERVENTIONS APPLIED TO PEOPLE WITH METS HAS CONSIDERABLE BENEFICIAL EFFECTS ON DISEASE PREVENTIVE OUTCOMES. THIS STUDY AIMED TO EXAMINE THE EFFECTS OF 1-YEAR OF YOGA EXERCISE ON THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY, HYPERTENSION, DYSLIPIDEMIA AND HYPERGLYCEMIA IN MIDDLE-AGED AND OLDER HONG KONG CHINESE ADULTS WITH METS. METHODS: ADULTS DIAGNOSED WITH METS USING NATIONAL CHOLESTEROL EDUCATION PROGRAM CRITERIA (N = 182; MEAN +/- SD AGE = 56 +/- 9.1) WERE RANDOMLY ASSIGNED TO A 1-YEAR YOGA INTERVENTION GROUP OR CONTROL GROUP. SYSTOLIC AND DIASTOLIC BLOOD PRESSURE, WAIST CIRCUMFERENCE, FASTING PLASMA GLUCOSE, TRIGLYCERIDES, AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WERE EXAMINED AT BASELINE, MIDWAY, AND ON COMPLETION OF THE STUDY. PHYSICAL ACTIVITY LEVEL AND CALORIC INTAKE WERE ASSESSED AND INCLUDED IN THE COVARIATE ANALYSES. RESULTS: A REDUCTION OF THE NUMBER OF DIAGNOSTIC COMPONENTS FOR METS WAS FOUND TO BE ASSOCIATED WITH THE YOGA INTERVENTION. WAIST CIRCUMFERENCE WAS SIGNIFICANTLY IMPROVED AFTER THE 1-YEAR YOGA INTERVENTION. A TREND TOWARDS A DECREASE IN SYSTOLIC BLOOD PRESSURE WAS OBSERVED FOLLOWING YOGA INTERVENTION. CONCLUSION: THESE RESULTS SUGGEST THAT YOGA EXERCISE IMPROVES THE CARDIOVASCULAR RISK FACTORS INCLUDING CENTRAL OBESITY AND BLOOD PRESSURE IN MIDDLE-AGED AND OLDER ADULTS WITH METS. THESE FINDINGS SUPPORT THE COMPLEMENTARY BENEFICIAL ROLE OF YOGA IN MANAGING METS. 2015 8 724 54 EFFECT OF LAUGHTER YOGA ON MOOD AND HEART RATE VARIABILITY IN PATIENTS AWAITING ORGAN TRANSPLANTATION: A PILOT STUDY. CONTEXT: RESEARCH SHOWS THAT LAUGHTER HAS MYRIAD HEALTH BENEFITS, YET THE MEDICAL COMMUNITY HAS NOT IMPLEMENTED IT FORMALLY AS A TREATMENT. PATIENTS AWAITING ORGAN TRANSPLANTATION HAVE SIGNIFICANT PHYSICAL DISABILITIES AND ARE AT RISK FOR PSYCHOLOGICAL DISTRESS. ATTENUATED HEART RATE VARIABILITY (HRV) IS A RISK FACTOR FOR A NEGATIVE LONG-TERM OUTCOME IN SOME PATIENTS. OBJECTIVE: THE STUDY INTENDED TO EVALUATE THE CLINICAL UTILITY OF LAUGHTER YOGA IN IMPROVING PSYCHOLOGICAL AND PHYSIOLOGICAL MEASURES IN OUTPATIENTS AWAITING ORGAN TRANSPLANTATION. POSITIVE RESULTS WOULD INDICATE PROMISING AREAS TO PURSUE IN A FOLLOW-UP STUDY. DESIGN: SIX PARTICIPANTS MET FOR 10 SESSIONS OVER 4 WEEKS. THE RESEARCH TEAM MEASURED EACH PARTICIPANT'S HEART RATE, HRV, BLOOD PRESSURE (BP), AND IMMEDIATE MOOD BEFORE AND AFTER THE LAUGHTER AND CONTROL INTERVENTIONS. THE TEAM ASSESSED PARTICIPANTS' LONGER-TERM MOOD (ANXIETY AND DEPRESSION) AT THE STUDY'S INITIATION, AFTER A NO-TREATMENT CONTROL WEEK, AND AT THE END OF THE STUDY. SETTING: THE STUDY OCCURRED AT THE DEPARTMENT OF SURGERY AND MEDICINE AT THE UNIVERSITY OF ARIZONA HEALTH SCIENCES CENTER, TUCSON. PARTICIPANTS: PARTICIPANTS WERE PATIENTS AWAITING TRANSPLANTS (THREE HEART AND THREE LUNG), TWO WOMEN AND FOUR MEN (AGES 51-69 Y). PARTICIPANTS HAD RECEIVED NO MAJOR SURGERY IN THE 3 MONTHS PRIOR TO THE INTERVENTION, DID NOT HAVE A HERNIA OR UNCONTROLLED HYPERTENSION, AND DID NOT FALL INTO THE NEW YORK HEART ASSOCIATION FUNCTION CLASS 4. INTERVENTION: THE 20-MINUTE LAUGHTER INTERVENTION INVOLVED BREATHING AND STRETCHING EXERCISES, SIMULATED LAUGHTER (IE, UNCONDITIONAL LAUGHTER THAT IS NOT CONTINGENT ON THE ENVIRONMENT), CHANTING, CLAPPING, AND A MEDITATION. THE 20-MINUTE CONTROL INTERVENTION INVOLVED THE STUDY'S PERSONNEL DISCUSSING HEALTH AND STUDY-RELATED TOPICS WITH THE PARTICIPANTS. OUTCOME MEASURES: THE RESEARCH TEAM MEASURED BP, HEART RATE, AND HRV AND ADMINISTERED THE PROFILE OF MOOD STATES, BECK ANXIETY INVENTORY, AND BECK DEPRESSION INVENTORY-II TO EVALUATE IMMEDIATE AND LONGER-TERM MOOD. THE TEAM HAD PLANNED QUANTITATIVE STATISTICAL ANALYSIS OF THE DATA AT THE STUDY'S INITIATION BUT DID NOT COMPLETE IT BECAUSE THE NUMBER OF ENROLLED PARTICIPANTS WAS TOO LOW FOR THE ANALYSIS TO BE MEANINGFUL. THE TEAM VISUALLY EXAMINED THE DATA, HOWEVER, FOR TRENDS THAT WOULD INDICATE AREAS TO EXAMINE FURTHER IN A FOLLOW-UP STUDY. RESULTS: PARTICIPANTS SHOWED IMPROVED IMMEDIATE MOOD (VIGOR-ACTIVITY AND FRIENDLINESS) AND INCREASED HRV AFTER THE LAUGHTER INTERVENTION. BOTH THE LAUGHTER AND CONTROL INTERVENTIONS APPEARED TO IMPROVE LONGER-TERM ANXIETY. TWO PARTICIPANTS AWAITING A LUNG TRANSPLANT DROPPED OUT OF THE STUDY, AND NO ADVERSE EVENTS OCCURRED. CONCLUSION: THIS PILOT STUDY SUGGESTS THAT LAUGHTER YOGA MAY IMPROVE HRV AND SOME ASPECTS OF MOOD, AND THIS TOPIC WARRANTS FURTHER RESEARCH. 2012 9 1298 34 HATHA YOGA AND VASCULAR FUNCTION: RESULTS FROM CROSS-SECTIONAL AND INTERVENTIONAL STUDIES. THE AIM OF THIS STUDY WAS TO DETERMINE THE EFFECT OF HATHA YOGA ON ARTERIAL ELASTICITY AND ENDOTHELIAL FUNCTION. FIRST, A CROSS-SECTIONAL STUDY WAS PERFORMED TO DETERMINE WHETHER YOGA PRACTITIONERS WOULD DEMONSTRATE GREATER ARTERIAL COMPLIANCE AND ENDOTHELIUM-DEPENDENT VASODILATION THAN THEIR SEDENTARY PEERS. SECOND, AN INTERVENTION STUDY INVOLVING 13 SEDENTARY MIDDLE-AGED AND OLDER ADULTS (51 +/- 7 YEARS) WAS PERFORMED TO DETERMINE WHETHER 12 WEEKS OF HATHA YOGA WOULD ELICIT INCREASES IN ARTERIAL COMPLIANCE AND ENDOTHELIAL FUNCTION. IN THE CROSS-SECTIONAL STUDY INVOLVING A TOTAL OF 34 SUBJECTS, THERE WERE NO GROUP DIFFERENCES IN BODY FATNESS, BLOOD LIPID AND LIPOPROTEIN CONCENTRATIONS, CAROTID ARTERY COMPLIANCE OR BRACHIAL ARTERY FLOW-MEDIATED DILATION (FMD). HEMOGLOBIN A1C WAS LOWER IN YOGA PRACTITIONERS THAN IN SEDENTARY ADULTS (P < 0.05). TOTAL CHOLESTEROL AND HEMOGLOBIN A1C DECREASED AFTER THE INTERVENTION (P < 0.05) WHILE CAROTID ARTERY COMPLIANCE AND BRACHIAL ARTERY FMD DID NOT CHANGE. THE RESULTS OF BOTH CROSS-SECTIONAL AND INTERVENTIONAL STUDIES INDICATE THAT REGULAR PRACTICE OF HATHA YOGA IS NOT ASSOCIATED WITH IMPROVEMENTS IN VASCULAR FUNCTIONS. 2013 10 2273 39 THE ROLE OF YOGA IN THE MANAGEMENT OF BLADDER PAIN SYNDROME: A SINGLE-ARM PILOT STUDY. BACKGROUND: BLADDER PAIN SYNDROME (BPS) IS A DEVASTATING UROLOGIC CONDITION CHARACTERIZED BY IRRITATIVE BLADDER SYMPTOMS, PELVIC PAIN, AND DYSPAREUNIA. FIRST-LINE TREATMENT INCLUDES DIETARY, SELF-CARE AND BEHAVIORAL MODIFICATIONS. THE ANCIENT PRACTICE OF YOGA IS WELL SUITED TO TREAT BPS, BUT EVIDENCE IS LACKING ON ITS USE. AIMS: TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF AN INTEGRATED YOGA MODULE ON BPS OUTCOMES AS MEASURED BY SELF-REPORTED QUESTIONNAIRES FROM BASELINE TO 3 MONTHS AFTER THERAPY. METHODS AND MATERIALS: THIS WAS A PROSPECTIVE SINGLE-ARM STUDY OF 8 PATIENTS WHO UNDERWENT 3 MONTHS OF INTEGRATED YOGA THERAPY. THE TREATMENT MODULE WAS PERFORMED 3 TO 4 TIMES WEEKLY AT HOME WITH 1 SESSION PERFORMED WEEKLY IN-OFFICE DURING THE FIRST MONTH TO ENSURE PROPER PERFORMANCE OF POSTURES. PATIENTS COMPLETED QUESTIONNAIRES (PELVIC PAIN AND URGENCY/FREQUENCY PATIENT SYMPTOM SCALE [PUF], PELVIC FLOOR IMPACT QUESTIONNAIRE - SHORT FORM 7 [PFIQ-7], SHORT FORM 36 QUESTIONNAIRE [SF-36], PITTSBURGH SLEEP QUALITY INDEX [PSQI]) AT BASELINE AND 3 MONTHS, INCLUDING PATIENT GLOBAL IMPRESSION OF IMPROVEMENT (PGI-I) AT THE 3-MONTH FOLLOW-UP VISIT. VOIDING DIARIES WERE ALSO REQUESTED AT BASELINE AND AT THE 3-MONTH ASSESSMENT. RESULTS: THERE WAS A TREND TOWARD IMPROVEMENT REGARDING PATIENTS' RESPONSES TO ALL QUESTIONNAIRES 3 MONTHS AFTER YOGA THERAPY, WITH THE ONLY STATISTICALLY SIGNIFICANT IMPROVEMENTS NOTED IN SOCIAL FUNCTION AND PAIN COMPONENTS OF THE SF-36. THERE WERE NO SIGNIFICANT CHANGES NOTED ON THE VOIDING DIARIES EXCEPT A NON-STATISTICALLY SIGNIFICANT TREND TOWARD INCREASED VOIDED VOLUMES. PATIENTS RATED THEIR EXPERIENCES WITH YOGA THERAPY POSITIVELY. CONCLUSIONS: YOGA THERAPY FOR BPS SHOWED EVIDENCE OF BENEFIT FOR IMPROVING BOTHERSOME BLADDER SYMPTOMS, PAIN AND VOIDING. A RANDOMIZED CONTROLLED TRIAL WILL FOLLOW TO INVESTIGATE THE EFFICACY OF THIS YOGA MODULE AGAINST A CONTROL GROUP. 2020 11 324 26 ANTHROPOMETRIC, BIOCHEMICAL AND CLINICAL PARAMETERS IN CLIMACTERIC YOGA PRACTITIONERS. OBJECTIVE: THIS STUDY AIMED TO EVALUATE ANTHROPOMETRIC, BIOCHEMICAL AND CLINICAL PARAMETERS IN CLIMACTERIC YOGA PRACTITIONERS. METHODS: THIS STUDY INVESTIGATED 108 CLIMACTERIC WOMEN. WE RECRUITED 28 WOMEN BETWEEN 40 AND 65 YEARS OLD WHO STARTED YOGA PRACTICES IN PREMENOPAUSE AND HAD ALREADY PRACTICED FOR AT LEAST 5 YEARS. AS CONTROLS, WE SELECTED 30 PHYSICAL ACTIVITY (PA) PRACTITIONERS WHO HAD PRACTICED FOR AT LEAST 5 YEARS AND 50 SEDENTARY WOMEN IN THE SAME AGE RANGE. WE CONDUCED ANTHROPOMETRIC, BIOCHEMICAL AND BLOOD PRESSURE MEASUREMENTS. RESULTS: THE YOGA GROUP HAD SIGNIFICANTLY LOWER FASTING BLOOD GLUCOSE THAN THE PA PRACTITIONERS AND SEDENTARY WOMEN. YOGA PRACTITIONERS ALSO HAD LOWER WEIGHT, BODY MASS INDEX, WAIST CIRCUMFERENCE, BODY FAT PERCENTAGE AND WAIST-TO-HEIGHT RATIO; HIGHER LEVELS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL; LOWER LEVELS OF TRIGLYCERIDES, INSULIN, HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE, URIC ACID, APOLIPOPROTEIN B AND HIGH-SENSITIVITY C-REACTIVE PROTEIN; AND LOWER FREQUENCY OF METABOLIC SYNDROME, LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX AND SYSTOLIC BLOOD PRESSURE THAN THE SEDENTARY WOMEN. CONCLUSION: YOGA PRACTITIONERS HAD LOWER GLUCOSE SERUM CONCENTRATIONS THAN THE PA PRACTITIONERS AND SEDENTARY WOMEN. OVERALL, THE YOGA GROUP ALSO HAD BETTER ANTHROPOMETRIC, BIOCHEMICAL AND CLINICAL VARIABLES THAN THE OTHER GROUPS. ALTHOUGH FURTHER INVESTIGATION IS REQUIRED, YOGA PRACTICE IN PREMENOPAUSE SEEMS TO BE BENEFICIAL FOR WOMEN WHEN THEY REACH MENOPAUSE. 2022 12 2834 40 YOGA'S EFFECT ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION - A CONTROLLED TRIAL IN PRIMARY CARE. BACKGROUND: YOGA CAN REDUCE BLOOD PRESSURE AND HAS ALSO BEEN SUGGESTED TO REDUCE INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASES (CVDS). WE AIMED TO ASSESS THE BENEFIT OF TWO YOGA INTERVENTIONS ON INFLAMMATORY BIOMARKERS AND METABOLIC RISK FACTORS IN A HIGH RISK POPULATION IN PRIMARY CARE. METHODS: ADULT PATIENTS FROM A HEALTH CARE CENTER IN SWEDEN, WITH DIAGNOSED HYPERTENSION, WERE INVITED TO UNDERGO A BASELINE CHECK AT THE HEALTH CARE CENTER. BASELINE CHECK INCLUDED STANDARDIZED BLOOD PRESSURE MEASUREMENT, BMI AND WEIGHT CIRCUMFERENCE MEASUREMENTS, BLOOD SAMPLING (HS-CRP, IL-6, FP-GLUCOSE, HBA1C, CHOLESTEROL, TG, LDL AND HDL) AND A QUESTIONNAIRE ON SELF-RATED QUALITY OF LIFE (WHOQOL-BREF). THERE WERE THREE GROUPS: 1) YOGA CLASS WITH YOGA INSTRUCTOR; 2) YOGA AT HOME; AND 3) A CONTROL GROUP. IN TOTAL, 83 PATIENTS WERE INCLUDED AND MATCHED AT THE GROUP LEVEL FOR SYSTOLIC BLOOD PRESSURE. A MAJORITY OF THE PATIENTS (92 %) WERE ON ANTIHYPERTENSIVE MEDICATION, WHICH THEY WERE REQUESTED NOT TO CHANGE DURING THE STUDY. AFTER 12 WEEKS OF INTERVENTION, THE ASSESSMENTS WERE PERFORMED AGAIN. RESULTS: WE RECORDED NO EVIDENCE THAT YOGA ALTERED INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS IN OUR STUDY POPULATION. A TOTAL OF 49 PARTICIPANTS (59 %) MET THE CRITERIA FOR METABOLIC SYNDROME. CONCLUSION: THE YOGA INTERVENTIONS PERFORMED IN OUR STUDY DID NOT AFFECT INFLAMMATORY BIOMARKERS OR METABOLIC RISK FACTORS ASSOCIATED WITH CVD IN THE STUDY POPULATION OF PRIMARY CARE PATIENTS WITH HYPERTENSION. FURTHER RANDOMIZED TRIALS ARE NEEDED TO ELUCIDATE THE EFFECTS OF YOGA ON CVD RISK FACTORS IN THIS PARTICULAR GROUP. TRAIL REGISTRATION: NCT01302535 , FEBRUARY 22, 2011. 2015 13 451 37 CHANGES IN FATIGUE, AUTONOMIC FUNCTIONS, AND BLOOD BIOMARKERS DUE TO SITTING ISOMETRIC YOGA IN PATIENTS WITH CHRONIC FATIGUE SYNDROME. BACKGROUND: IN A PREVIOUS RANDOMIZED CONTROLLED TRIAL, WE FOUND THAT SITTING ISOMETRIC YOGA IMPROVES FATIGUE IN PATIENTS WITH CHRONIC FATIGUE SYNDROME (CFS) WHO ARE RESISTANT TO CONVENTIONAL THERAPY. THE AIM OF THIS STUDY WAS TO INVESTIGATE POSSIBLE MECHANISMS BEHIND THIS FINDING, FOCUSING ON THE SHORT-TERM FATIGUE-RELIEVING EFFECT, BY COMPARING AUTONOMIC NERVOUS FUNCTION AND BLOOD BIOMARKERS BEFORE AND AFTER A SESSION OF ISOMETRIC YOGA. METHODS: FIFTEEN PATIENTS WITH CFS WHO REMAINED SYMPTOMATIC DESPITE AT LEAST 6 MONTHS OF CONVENTIONAL THERAPY PRACTICED SITTING ISOMETRIC YOGA (BIWEEKLY 20 MIN PRACTICE WITH A YOGA INSTRUCTOR AND DAILY HOME PRACTICE) FOR EIGHT WEEKS. ACUTE EFFECTS OF SITTING ISOMETRIC YOGA ON FATIGUE, AUTONOMIC FUNCTION, AND BLOOD BIOMARKERS WERE INVESTIGATED AFTER THE FINAL SESSION WITH AN INSTRUCTOR. THE EFFECT OF A SINGLE SESSION OF SITTING ISOMETRIC YOGA ON FATIGUE WAS ASSESSED BY THE PROFILE OF MOOD STATUS (POMS) QUESTIONNAIRE IMMEDIATELY BEFORE AND AFTER THE SESSION. AUTONOMIC NERVOUS FUNCTION (HEART RATE (HR) VARIABILITY) AND BLOOD BIOMARKERS (CORTISOL, DHEA-S, TNF-ALPHA, IL-6, IFN-GAMMA, IFN-ALPHA, PROLACTIN, CARNITINE, TGF-BETA1, BDNF, MHPG, AND HVA) WERE COMPARED BEFORE AND AFTER THE SESSION. RESULTS: SITTING ISOMETRIC YOGA SIGNIFICANTLY REDUCED THE POMS FATIGUE SCORE (P < 0.01) AND INCREASED THE VIGOR SCORE (P < 0.01). IT ALSO REDUCED HR (P < 0.05) AND INCREASED THE HIGH FREQUENCY POWER (P < 0.05) OF HR VARIABILITY. SITTING ISOMETRIC YOGA INCREASED SERUM LEVELS OF DHEA-S (P < 0.05), REDUCED LEVELS OF CORTISOL (P < 0.05) AND TNF-ALPHA (P < 0.05), AND HAD A TENDENCY TO REDUCE SERUM LEVELS OF PROLACTIN (P < 0.1). DECREASES IN FATIGUE SCORES CORRELATED WITH CHANGES IN PLASMA LEVELS OF TGF-BETA1 AND BDNF. IN CONTRAST, INCREASED VIGOR POSITIVELY CORRELATED WITH HVA. CONCLUSIONS: A SINGLE SESSION OF SITTING ISOMETRIC YOGA REDUCED FATIGUE AND INCREASED VIGOR IN PATIENTS WITH CFS. YOGA ALSO INCREASED VAGAL NERVE FUNCTION AND CHANGED BLOOD BIOMARKERS IN A PATTERN THAT SUGGESTED ANTI-STRESS AND ANTI-INFLAMMATORY EFFECTS. THESE CHANGES APPEAR TO BE RELATED TO THE SHORT-TERM FATIGUE-RELIEVING EFFECT OF SITTING ISOMETRIC YOGA IN PATIENTS WITH CFS. FURTHERMORE, DOPAMINERGIC NERVOUS SYSTEM ACTIVATION MIGHT ACCOUNT FOR SITTING ISOMETRIC YOGA-INDUCED INCREASES IN ENERGY IN THIS PATIENT POPULATION. TRIAL REGISTRATION: UNIVERSITY HOSPITAL MEDICAL INFORMATION NETWORK (UMIN CTR) UMIN000009646. REGISTERED DEC 27, 2012. 2018 14 300 27 AN ASSESSMENT OF A SEQUENCE OF YOGA EXERCISES TO PATIENTS WITH ARTERIAL HYPERTENSION. THIS QUASI-EXPERIMENTAL STUDY DESCRIBES THE EFFECTS OF A YOGA SEQUENCE FOLLOWING HEMODYNAMIC AND BIOCHEMICAL PARAMETERS IN PATIENTS WITH HYPERTENSION. THIRTY-THREE VOLUNTEERS PARTICIPATED IN THE STUDY (CONTROL = 16 AND YOGA = 17) FOR FOUR MONTHS. BLOOD PRESSURE MEASUREMENTS, CARDIAC AND RESPIRATORY RATE WERE COLLECTED MONTHLY, WHILE THE BIOCHEMICAL PROFILE WAS TAKEN AT THE BEGINNING AND END OF THE PROGRAM. TO ANALYZE THE DATA, STUDENT'S T TEST AND REPEATED MEASURES ANALYSES WERE PERFORMED. THE YOGA GROUP SHOWED A SIGNIFICANT REDUCTION OF SYSTOLIC BLOOD PRESSURE, HEART AND RESPIRATORY RATE (P < 0.05). AS FOR THE BIOCHEMICAL PROFILE, THE YOGA GROUP SHOWED CORRELATION COEFFICIENTS BETWEEN INITIAL VALUES AND FINAL RESPONSES GREATER THAN THE CONTROL OF FASTING GLUCOSE, TOTAL CHOLESTEROL, LDL-CHOLESTEROL AND TRIGLYCERIDES. THE ELABORATED SEQUENCE PRACTICE PROMOTED SIGNIFICANT CARDIOVASCULAR AND METABOLIC BENEFITS. THE YOGA EXERCISES PERFORMED IN THE PROPOSED SEQUENCE CONSTITUTE COMPLEMENTARY NON-PHARMACOLOGICAL CONTROL OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION. 2013 15 2744 61 YOGA PRACTICE IMPROVES PHYSIOLOGICAL AND BIOCHEMICAL STATUS AT HIGH ALTITUDES: A PROSPECTIVE CASE-CONTROL STUDY. UNLABELLED: CONTEXT * HIGH ALTITUDE (HA) IS A PSYCHOPHYSIOLOGICAL STRESSOR FOR NATIVES OF LOWER ALTITUDES. REDUCING THE MORBIDITY AND OPTIMIZING THE PERFORMANCE OF INDIVIDUALS DEPLOYED IN AN HA REGION HAS BEEN ATTEMPTED AND REPORTED WITH VARIED RESULTS. OBJECTIVE * THE PRESENT STUDY INTENDED TO EXPLORE THE EFFECTS OF COMPREHENSIVE YOGIC PRACTICES ON THE HEALTH AND PERFORMANCE OF INDIAN SOLDIERS DEPLOYED AT HAS. DESIGN * THE RESEARCH TEAM DESIGNED A PROSPECTIVE, RANDOMIZED, CASE-CONTROL STUDY. SETTING: THE STUDY WAS DONE AT KARU, LEH, INDIA, AT AN ALTITUDE OF 3445 M. PARTICIPANTS * FULLY ACCLIMATIZED SOLDIERS IN THE INDIAN ARMY WERE RANDOMLY SELECTED FROM THOSE POSTED TO HA REGIONS (IE, ALTITUDES >3000 M). INTERVENTION * THE SOLDIERS WERE DIVIDED INTO 2 GROUPS OF EQUAL SIZE. THE FIRST GROUP, THE CONTROL GROUP, CARRIED OUT THE ROUTINE ACTIVITIES FOR PHYSICAL TRAINING IN THE INDIAN ARMY. THE SECOND GROUP, THE INTERVENTION GROUP PRACTICED A COMPREHENSIVE YOGA PACKAGE, INCLUDING PHYSICAL ASANAS, PRANAYAMA, AND MEDITATION, AND DID NOT PERFORM THE PHYSICAL TRAINING THAT THE FIRST GROUP DID. BOTH GROUPS WERE MONITORED DURING THEIR ACTIVITIES. OUTCOME MEASURES * A WIDE AND COMPREHENSIVE RANGE OF ANTHROPOMETRICAL, PHYSIOLOGICAL, BIOCHEMICAL, AND PSYCHOLOGICAL PARAMETERS WERE MEASURED: (1) HEIGHT AND WEIGHT; (2) BODY FAT PERCENTAGE (BFP); (3) HEART RATE (HR); (4) RESPIRATORY RATE (RR); (5) SYSTOLIC AND DIASTOLIC BLOOD PRESSURE (DPB); (6) PERIPHERAL SATURATION OF OXYGEN; (7) END TIDAL CO2 (ETCO2); (8) CHEST EXPANSION; (9) PULMONARY FUNCTION; (10) PHYSICAL WORK CAPACITY (VO2MAX); (11) HEMATOLOGICAL VARIABLES; (12) LIPID PROFILE; (13) SERUM UREA; (14) CREATININE; (15) LIVER ENZYMES; (16) BLOOD GLUCOSE; AND (17) ANXIETY SCORES. MEASUREMENTS WERE MADE AT BASELINE AND POSTINTERVENTION. RESULTS * TWO-HUNDRED SOLDIERS TOOK PART IN THE STUDY. THE YOGA GROUP SHOWED A SIGNIFICANT IMPROVEMENT IN HEALTH INDICES AND PERFORMANCE AS COMPARED WITH THE CONTROL GROUP. THEY HAD LOWER WEIGHTS, BFPS, RRS, DBPS, AND ANXIETY SCORES. THEY ALSO HAD A SIGNIFICANTLY HIGHER ETCO2, FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME IN THE FIRST SECOND (FEV1), AND VO2MAX. ALSO, THE YOGA GROUP SHOWED A SIGNIFICANT REDUCTION IN SERUM CHOLESTEROL, LOW-DENSITY LIPOPROTEIN, TRIGLYCERIDES, AND BLOOD UREA AS COMPARED WITH THEIR PREYOGA LEVELS AND WITH THE EXERCISE GROUP. CONCLUSIONS * PRACTICE OF YOGA FACILITATES IMPROVEMENTS IN HEALTH AND PERFORMANCE AT HAS AND IS SUPERIOR TO ROUTINE TRAINING WITH PHYSICAL EXERCISES. COMPREHENSIVE YOGIC PRACTICES ARE AN EFFECTIVE MODALITY FOR IMPROVING HEALTH AND PERFORMANCE AT HAS. 2016 16 174 34 A RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFECTS OF YOGA WITH AN ACTIVE CONTROL ON AMBULATORY BLOOD PRESSURE IN INDIVIDUALS WITH PREHYPERTENSION AND STAGE 1 HYPERTENSION. THE PURPOSE OF THIS STUDY WAS TO COMPARE THE EFFECTS OF YOGA WITH AN ACTIVE CONTROL (NONAEROBIC EXERCISE) IN INDIVIDUALS WITH PREHYPERTENSION AND STAGE 1 HYPERTENSION. A RANDOMIZED CLINICAL TRIAL WAS PERFORMED USING TWO ARMS: (1) YOGA AND (2) ACTIVE CONTROL. PRIMARY OUTCOMES WERE 24-HOUR DAY AND NIGHT AMBULATORY SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. WITHIN-GROUP AND BETWEEN-GROUP ANALYSES WERE PERFORMED USING PAIRED T TESTS AND REPEATED-MEASURES ANALYSIS OF VARIANCE (TIME X GROUP), RESPECTIVELY. EIGHTY-FOUR PARTICIPANTS ENROLLED, WITH 68 PARTICIPANTS COMPLETING THE TRIAL. WITHIN-GROUP ANALYSES FOUND 24-HOUR DIASTOLIC, NIGHT DIASTOLIC, AND MEAN ARTERIAL PRESSURE ALL SIGNIFICANTLY REDUCED IN THE YOGA GROUP (-3.93, -4.7, -4.23 MM HG, RESPECTIVELY) BUT NO SIGNIFICANT WITHIN-GROUP CHANGES IN THE ACTIVE CONTROL GROUP. DIRECT COMPARISONS OF THE YOGA INTERVENTION WITH THE CONTROL GROUP FOUND A SINGLE BLOOD PRESSURE VARIABLE (DIASTOLIC NIGHT) TO BE SIGNIFICANTLY DIFFERENT (P=.038). THIS STUDY HAS DEMONSTRATED THAT A YOGA INTERVENTION CAN LOWER BLOOD PRESSURE IN PATIENTS WITH MILD HYPERTENSION. ALTHOUGH THIS STUDY WAS NOT ADEQUATELY POWERED TO SHOW BETWEEN-GROUP DIFFERENCES, THE SIZE OF THE YOGA-INDUCED BLOOD PRESSURE REDUCTION APPEARS TO JUSTIFY PERFORMING A DEFINITIVE TRIAL OF THIS INTERVENTION TO TEST WHETHER IT CAN PROVIDE MEANINGFUL THERAPEUTIC VALUE FOR THE MANAGEMENT OF HYPERTENSION. 2014 17 1533 32 IYENGAR YOGA VERSUS ENHANCED USUAL CARE ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION TO STAGE I HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL. THE PREVALENCE OF PREHYPERTENSION AND STAGE 1 HYPERTENSION CONTINUES TO INCREASE DESPITE BEING AMENABLE TO NON-PHARMACOLOGIC INTERVENTIONS. IYENGAR YOGA (IY) HAS BEEN PURPORTED TO REDUCE BLOOD PRESSURE (BP) THOUGH EVIDENCE FROM RANDOMIZED TRIALS IS LACKING. WE CONDUCTED A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTS OF 12 WEEKS OF IY VERSUS ENHANCED USUAL CARE (EUC) (BASED ON INDIVIDUAL DIETARY ADJUSTMENT) ON 24-H AMBULATORY BP IN YOGA-NAIVE ADULTS WITH UNTREATED PREHYPERTENSION OR STAGE 1 HYPERTENSION. IN TOTAL, 26 AND 31 SUBJECTS IN THE IY AND EUC ARMS, RESPECTIVELY, COMPLETED THE STUDY. THERE WERE NO DIFFERENCES IN BP BETWEEN THE GROUPS AT 6 AND 12 WEEKS. IN THE EUC GROUP, 24-H SYSTOLIC BP (SBP), DIASTOLIC BP (DBP) AND MEAN ARTERIAL PRESSURE (MAP) SIGNIFICANTLY DECREASED BY 5, 3 AND 3 MMHG, RESPECTIVELY, FROM BASELINE AT 6 WEEKS (P < .05), BUT WERE NO LONGER SIGNIFICANT AT 12 WEEKS. IN THE IY GROUP, 24 H SBP WAS REDUCED BY 6 MMHG AT 12 WEEKS COMPARED TO BASELINE (P = .05). 24 H DBP (P < .01) AND MAP (P < .05) DECREASED SIGNIFICANTLY EACH BY 5 MMHG. NO DIFFERENCES WERE OBSERVED IN CATECHOLAMINE OR CORTISOL METABOLISM TO EXPLAIN THE DECREASE IN BP IN THE IY GROUP AT 12 WEEKS. TWELVE WEEKS OF IY PRODUCES CLINICALLY MEANINGFUL IMPROVEMENTS IN 24 H SBP AND DBP. LARGER STUDIES ARE NEEDED TO ESTABLISH THE LONG TERM EFFICACY, ACCEPTABILITY, UTILITY AND POTENTIAL MECHANISMS OF IY TO CONTROL BP. 2011 18 859 39 EFFECT OF YOGA PRACTICE ON LEVELS OF INFLAMMATORY MARKERS AFTER MODERATE AND STRENUOUS EXERCISE. BACKGROUND AND OBJECTIVES: TO EVALUATE THE EFFECT OF YOGA PRACTICE AND EXERCISE CHALLENGE ON TUMOUR NECROSIS FACTOR ALPHA (TNF-ALPHA), INTERLEUKIN-6 (IL-6) LEVELS AND LIPID PROFILE. MATERIALS AND METHODS: TWO HUNDRED AND EIGHTEEN SUBJECTS PARTICIPATED IN THE STUDY. ONE HUNDRED AND NINE VOLUNTEERS (51 MALES AND 58 FEMALES) IN THE AGE GROUP OF 20 TO 60 YEARS, WHO PRACTICED YOGA REGULARLY FOR OVER FIVE YEARS FOR A PERIOD OF ONE HOUR DAILY, PERFORMED A BOUT OF MODERATE EXERCISE AND A BOUT OF STRENUOUS EXERCISE AS PER STANDARDIZED SHUTTLE WALK TEST PROTOCOL. ANTHROPOMETRICALLY MATCHED, AGE MATCHED AND GENDER MATCHED SUBJECTS, WHO DID NOT PRACTICE YOGA (NON-YOGA GROUP) WERE CHOSEN AS CONTROLS (NON-YOGA, N=109). THE NON-YOGA GROUP ALSO PERFORMED SIMILAR EXERCISES. THE BLOOD SAMPLES OF BOTH THE GROUPS WERE COLLECTED BEFORE AND AFTER THE EXERCISES. TNF-ALPHA AND IL-6 WAS ANALYSED BEFORE AND AFTER THE EXERCISE BY SANDWICH ELISA (ENZYME LINKED IMMUNOSORBENT ASSAY). RESULTS: RESTING PLASMA TNF-ALPHA CONCENTRATION WAS SIGNIFICANTLY HIGHER IN NON-YOGA GROUP WHEN COMPARED TO YOGA GROUP (P<0.05). THERE WAS AN INCREASE IN TNF-ALPHA LEVELS IN BOTH THE GROUPS IN RESPONSE TO STRENUOUS EXERCISE. THERE WAS NO GENDER DIFFERENCE IN TNF-ALPHA AND IL-6 LEVELS BEFORE AND AFTER EXERCISE IN YOGA AND NON-YOGA GROUPS. CONCLUSION: REGULAR PRACTICE OF YOGA LOWERS BASAL TNF-ALPHA AND IL-6 LEVELS. IT ALSO REDUCES THE EXTENT OF INCREASE OF TNF-ALPHA AND IL-6 TO A PHYSICAL CHALLENGE OF MODERATE EXERCISE AND STRENUOUS EXERCISE. THERE IS NO SIGNIFICANT GENDER DIFFERENCE IN THE TNF-ALPHA AND IL-6 LEVELS. REGULAR PRACTICE OF YOGA CAN PROTECT THE INDIVIDUAL AGAINST INFLAMMATORY DISEASES BY FAVOURABLY ALTERING PRO-INFLAMMATORY CYTOKINE LEVELS. 2015 19 389 30 BENEFITS OF YOGA FOR AFRICAN AMERICAN HEART FAILURE PATIENTS. BACKGROUND: THE NUMBER OF AFRICAN AMERICAN (AA) PATIENTS LIVING WITH HEART FAILURE (HF) HAS BEEN INCREASING, ESPECIALLY AMONG THE ECONOMICALLY DISADVANTAGED. YOGA THERAPY HAS BEEN FOUND TO IMPROVE PHYSICAL AND PSYCHOLOGICAL PARAMETERS AMONG HEALTHY INDIVIDUALS, BUT ITS EFFECT IN PATIENTS WITH HF REMAINS UNKNOWN. THE PURPOSE OF THIS STUDY WAS TO EXAMINE THE EFFECTS OF YOGA THERAPY ON CARDIOVASCULAR ENDURANCE (VO2PEAK), FLEXIBILITY, QUALITY OF LIFE (QOL), AND INFLAMMATORY MARKERS ON MEDICALLY STABLE HF PATIENTS. METHODS: FORTY PATIENTS (38 AA, 1 ASIAN, AND 1 CAUCASIAN) WITH SYSTOLIC OR DIASTOLIC HF WERE RANDOMIZED TO THE YOGA GROUP (YG, N = 21) OR THE CONTROL GROUP (CG, N = 19). ALL PATIENTS WERE ASKED TO FOLLOW A HOME WALK PROGRAM. PREMEASUREMENT AND POSTMEASUREMENT INCLUDED A TREADMILL STRESS TEST TO PEAK EXERTION, FLEXIBILITY, INTERLEUKIN-6 (IL-6), C-REACTIVE PROTEIN (CRP), AND EXTRACELLULAR SUPEROXIDE DISMUTASE (EC-SOD). QOL WAS ASSESSED BY THE MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE (MLWHFQ). RESULTS: THE STATISTICAL ANALYSES (ASSESSED BY ANOVA AND T-TESTS) WERE SIGNIFICANT FOR FAVORABLE CHANGES IN THE YG, COMPARED WITH THOSE IN THE CG, FOR FLEXIBILITY (P = 0.012), TREADMILL TIME (P = 0.002), VO2PEAK (P = 0.003), AND THE BIOMARKERS (IL-6, P = 0.004; CRP, P = 0.016; AND EC-SOD, P = 0.012). WITHIN THE YG, PRETEST TO POSTTEST SCORES FOR THE TOTAL (P = 0.02) AND PHYSICAL SUBSCALES (P < 0.001) OF THE MLWHFQ WERE IMPROVED. CONCLUSIONS: YOGA THERAPY OFFERED ADDITIONAL BENEFITS TO THE STANDARD MEDICAL CARE OF PREDOMINANTLY AA HF PATIENTS BY IMPROVING CARDIOVASCULAR ENDURANCE, QOL, INFLAMMATORY MARKERS, AND FLEXIBILITY. 2010 20 1552 40 LIFESTYLE MODIFICATION IN BLOOD PRESSURE STUDY II (LIMBS): STUDY PROTOCOL OF A RANDOMIZED CONTROLLED TRIAL ASSESSING THE EFFICACY OF A 24 WEEK STRUCTURED YOGA PROGRAM VERSUS LIFESTYLE MODIFICATION ON BLOOD PRESSURE REDUCTION. HYPERTENSION IS A MAJOR PUBLIC HEALTH ISSUE AFFECTING 68 MILLION ADULTS IN THE UNITED STATES. LIFESTYLE MODIFICATIONS INCLUDING COMPLEMENTARY THERAPIES SUCH AS THE MOVEMENT BASED MIND BODY PRACTICE OF YOGA HAVE BECOME INCREASINGLY POPULAR IN THE UNITED STATES AND HAVE BEEN CONSIDERED AS A POTENTIAL ALTERNATIVE TO MEDICATION IN BLOOD PRESSURE REDUCTION. WE COMPLETED A PILOT STUDY IN 2009 WHICH SHOWED MEANINGFUL DECREASES IN 24-HOUR AMBULATORY BLOOD PRESSURE READINGS AFTER A 12 WEEK PERIOD OF YOGA PARTICIPATION. BASED ON DATA FROM OUR PILOT STUDY WE ARE NOW COMPLETING THE LIFESTYLE MODIFICATION AND BLOOD PRESSURE STUDY (LIMBS II) WHICH IS A PHASE 2 RANDOMIZED CONTROLLED TRIAL DESIGNED TO DETERMINE THE EFFECTS OF YOGA THERAPY AND ENHANCED LIFESTYLE MODIFICATION ON LOWERING BLOOD PRESSURE IN PRE-HYPERTENSIVE AND STAGE 1 HYPERTENSIVE SUBJECTS. USING 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING, LIMBS II AIMS TO COMPARE THE EFFECTS ON BLOOD PRESSURE REDUCTION IN SUBJECTS RANDOMIZED FOR 24 WEEKS TO ONE OF THE THREE FOLLOWING GROUPS: YOGA THERAPY VERSUS BLOOD PRESSURE EDUCATION PROGRAM (SODIUM RESTRICTION AND WALKING PROGRAM) VERSUS A COMBINATION PROGRAM THAT INVOLVES COMPONENTS OF BOTH GROUPS. LIMBS II WILL ALSO EXAMINE THE IMPACT THAT CHANGES IN BLOOD PRESSURE HAVE ON CEREBRAL BLOOD FLOW. IF SUCCESSFUL, THE LIMBS STUDY WILL DETERMINE IF YOGA THERAPY COMBINED WITH ENHANCED LIFESTYLE MODIFICATION WILL RESULT IN CLINICALLY MEANINGFUL DECREASES IN BLOOD PRESSURE AND THUS CAN BE IMPLEMENTED AS AN ALTERNATIVE TO DRUG THERAPY FOR PATIENTS WITH PREHYPERTENSION AND STAGE 1 HYPERTENSION. 2013